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China had an estimated 1.3 million new
cases of tuberculosis (TB) in 2008, of
which 112,000 were multidrug resistant.
That is, nearly 0.1% of the Chinese
population developed TB for the first time
in 2008, accounting for one in seven new
cases worldwide [1,2]. Over the period
2001–2008, TB was the second largest
cause of death among China’s 39 notifi-
able communicable diseases, behind HIV/
AIDS [3].
The Ministry of Health first began to
scale up TB control in 1992 by adopting
the World Health Organization (WHO)
Directly Observed Treatment Short-
course (DOTS) strategy, covering 13 of
31 provinces (about half the national
population), assisted by a World Bank
loan. DOTS, now enhanced as the Stop
TB Strategy, advocates early diagnosis of
cases with active TB (target 70% of all new
sputum smear-positive cases to be detect-
ed), followed by combination chemother-
apy to achieve high cure rates (target
.85% treatment success) and reduce
transmission [1,4]. During the decade
1990–2000, this large project cut the
number of TB deaths in China by one
half (evaluated from routine surveillance
data) and the prevalence (measured in
cross-sectional surveys) by one third [5,6].
But when external funding ended in the
year 2000, efforts diminished and TB case
notifications declined, especially in some
World Bank project areas [7]. A special
study attached to the year 2000 national
prevalence survey highlighted some of the
persistent problems in TB control. For
instance, 92% of a sample of 1,278
patients were not covered by medical
insurance, and had sought diagnosis and
treatment at their own expense. Nearly
half (45%) of these patients failed to
complete treatment because costs were
too high [7].
The inadequacies of TB control at the
turn of the millennium were a stimulus to
do much better. In 2002, two new funding
initiatives were launched by the Chinese
government to reinvigorate DOTS, and
especially to improve TB control in poorer
areas of the country [7]. One initiative was
backed by a further loan from the World
Bank, with additional support from other
donors. The second was supported by a
donation from the Global Fund. Under-
pinning this external funding, the Chinese
Government—national, provincial, and in
counties—increased expenditure on TB
control nationwide from 2003 onwards
[7].
Here, we show how this combination of
increased domestic funding, supplemented
by foreign loans and donations, led to a
dramatic increase in TB case finding and,
potentially, more effective reductions in
TB burden. We also highlight the way in
which changes in TB control policy,
carried out in the wider context of health
system reforms, generate challenges for
monitoring and evaluation.
Evaluating the Impact of New
Funds for TB Control
We tracked the number of sputum
smear-positive TB cases reported by
China’s 2,859 counties to the National
TB Surveillance System (NTBSS) from 1
January 2001 to 31 December 2008 (Text
S1). Counties were mapped geographical-
ly, divided into three groups according to
the principal sources of funding (World
Bank, Global Fund, Chinese Govern-
ment), and classified according to income,
expenditure, literacy, and ethnicity. The
following analysis examines the link be-
tween domestic and foreign investment
(excluding private out-of-pocket expendi-
ture) and TB case notifications, in counties
of different kinds and with different
funding sources. Cost-effectiveness is
judged from the perspective of the gov-
ernment as health care provider.
Clusters and Hotspots of TB in
China
To decide how to allocate funds across
China, the spatial distribution of TB cases
was mapped to identify clusters (neigh-
bouring counties with similar TB notifica-
tion rates) and hotspots (counties with high
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Mapping revealed that about 70% of the
variation in the case notification rate was
among provinces and 30% among coun-
ties (Text S1). Most of the variation was
therefore on a larger (among provinces)
rather than smaller (among counties)
geographical scale (Figure 1A). However,
there was significant clustering of cases at
county level in each of the 6 years 2003–
2008. Persistent hotspots were detected in
western (Xinjiang, Neimeng, Gansu, Xi-
zang, Qinghai, Shaanxi provinces) and
central China (Hunan, Hubei, Henan,
Chongqing, Guizhou provinces), and
307,638 cases were reported from these
hotspots between 2003 and 2008, an
average of 31 cases/100,000 population/
year. Allowing for differences among
counties in age and sex, case notification
rates were higher in poorer counties, and
in countries populated by minority groups
(Text S1).
Scaling Up TB Control
The resources provided by external
donors, principally the World Bank and
the Global Fund, were matched by
funding from central and local govern-
ment and used to support TB control in
counties that are inhabited by more
disadvantaged people (Table 1). Between
2003 and 2008, 81%–98% of hotspots
were in World Bank and Global Fund
areas (Figure 1B–1G). All aspects of TB
control were improved from 2001 on-
wards: DOTS coverage increased from
44% of counties in 2001 to 100% in 2005;
more staff were recruited and trained (1.7
million trained in 2005 alone); more
laboratories were built (increasing in the
World Bank area from 992 in 2002 to
1,479 in 2008); diagnostic evaluation
became more intensive (1.7 million chest
X-rays taken in World Bank in 2002,
compared with 6.1 million in 2008); a
greater number of TB cases was identified
through routine health checks, as well as
among those with symptoms typical of TB
attending clinics; patient registration and
clinical management were improved; a
special fund was created for TB drugs, free
treatment was extended to smear-negative
patients; and health promotion was am-
plified through the various media. To
achieve this, the Chinese government
effectively combined domestic resources
with those provided by foreign donors—in
money and in kind (Text S1).
Increasing Case Notification
Rates
During the 1990s, the number of TB
cases (all forms) reported each year was
typically between 30 and 40 per 100,000
populations, but, with further investment,
began to increase in the early 2000s. A
total of 2.9 million new sputum smear-
positive cases were reported between 2001
and the end of 2008. The number of cases
reported per capita increased in World
Bank, Global Fund, and government-
supported areas (Chinese government)
from 2002 to 2005, and then stabilized
or began to fall (Figure 2A; Table 2; Text
S1). Compared with 2002, the increases by
2005 were much bigger in World Bank
(236%) and Global Fund (224%) than in
Chinese government areas (65%).
After 2001, more cases were found
among both males and females, but the
increase was greater among males, so that
the ratio of male/female cases nationwide
rose steadily from 2.1 to 2.5 over the 8-
year period to 2008 (Text S1). The
increase in the sex ratio was greater in
World Bank and Global Fund areas as
compared with Chinese government areas,
rising from 1.9 to 2.5 in World Bank and
Global Fund combined but only from 2.5
to 2.6 in the Chinese government. Within
World Bank and Global Fund areas, the
increase in sex ratio was predominantly in
the 15–64-year age class, and the sex ratio
in this age class had almost converged in
World Bank, Global Fund, and Chinese
government areas by 2008 (Figure 2B).
The intervention in World Bank and
Global Fund areas also favoured elderly
patients (.65 years), both males and
females, in comparison with patients aged
0–14 years and 15–64 years. The ratio of
older to younger adult cases increased
throughout the period 2001–2008 in
World Bank and Global Fund, but not
markedly in the Chinese government
(Figure 2C; Text S1).
The number of cases reported in chil-
dren 0–14 years also increased in all three
areas between 2002 (2,077 cases) and 2005
(3,282 cases), but this increase was smaller
(27%) than for all adults (143%). Finally, in
association with increases in notifications in
all three areas, the proportion of smear-
positive cases with recurrent TB after prior
treatment dropped from 15.1% in 2003 to
8.6% in 2006, indicating that cure rates
were improving.
Expenditure, Cases Notified,
and Cost-Effectiveness
The total government expenditure on
TB control for the period 2001–2008
was CNY5,198 million (US$743 million)
(Table 2; Text S1). Expenditures increased
in all areas from 2001 to 2005, and
budgets remained approximately stable
from 2006 to 2008. So the number of
cases reported from 2001 to 2008 has
closely tracked spending on TB control.
More than half of the national budget for
TB control was allocated to the World
Bank area in 2008.
The average cost per TB case notified
over the whole period 2001–2008 was
similar in World Bank, Global Fund, and
Chinese government areas (CNY1,763–
1,820, US$252–US$260). Approximately
94% of the 2.9 million new sputum smear-
positive cases were reported to be success-
fully treated in each of the three areas of the
country. Based on these treatment results,
the cost per case successfully treated in the
three areas over the period 2001–2008
was CNY1,857–1,930 (US$265–US$276;
Text S1).
Summary Points
N Responding to evidence that many individuals with tuberculosis (TB) did not
have access to treatment in 2001, especially in poorer areas of China, the
government changed its policy on TB control. Domestic TB funding was
increased nationwide, supported by a World Bank loan and donations from the
Global Fund and other foreign agencies.
N Under the new funding initiative, case notifications more than doubled
between 2002 and 2005, sufficient for China to reach the WHO targets of
detecting 70% of all new smear-positive cases and successfully treating 85% of
these cases nationwide.
N The cost of finding and successfully treating each case between 2003 and 2008
was estimated to be US$272 on average—a cost-effective policy by comparison
with other health interventions.
N While changes in TB control policy produced clear benefits in case finding, they
present two challenges for evaluation, concerning (1) the impact of better case
finding on TB transmission, case load, and mortality, and (2) the contribution to
TB control of system-wide improvements in health care initiated in 2003 and
2009.
PLoS Medicine | www.plosmedicine.org 2 November 2010 | Volume 7 | Issue 11 | e1000371Figure 1. (A) Average TB case notifications per 100,000 populations by county, 2001–2008. (B–G) Distribution of counties that were TB hotspots over
the period 2003–2008.
doi:10.1371/journal.pmed.1000371.g001
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of 2002 would have persisted from 2003 to
2005 without additional funding, 329,108,
134,219, and 80,712 additional cases were
found in World Bank, Global Fund, and
Chinese government areas over this 3-year
period. The incremental costs for each
extra case notified and put on treatment
were greater than the total costs per case,
but similar in all three areas despite
differences in the numbers of additional
cases reported. They were in the range
CNY2,696–2,890 (US$385–US$413;
Text S1).
China’s Changing Policy on TB
Control: What We Know and
Don’t Know
China’s approach to TB control since
2002 is a lesson in effectively managing
domesticand foreign investmentto improve
health. By stepping up domestic funding for
TB control, and adding in contributions
from external agencies, the Chinese gov-
ernment more than doubled the number of
cases reported each year. The biggest
annual increases in funding were between
2002 and 2005, and this injection of funds
apparently drove the large increases in
TB cases reported over this period. This
funding initiative has benefited children,
young adults and the elderly, men and
women, and TB cases living in all areas of
the country. But the greatest benefits were
for men (15–64 years), the elderly ($65
years), and those living in the poorest
counties, which were the focus of foreign
donor support. The extra benefits to men,
in particular, were not anticipated and
remain to be explained.
From the perspective of the government
as health provider, the average cost per
case successfully treated was estimated to
be CNY1,901 (US$272), which is a cost-
effective policy on TB control by interna-
tional standards. In studies carried out in
Egypt, India, Malawi, Mozambique, Syria,
Tanzania, and Thailand, also from the
provider perspective, the costs per cure for
outpatients treated by government health
services ranged up to US$400, which is
considered cost-effective among health
interventions [8].
Although many of the benefits of invest-
ment are clear, China’s changed policy on
TB control leaves at least two key questions
unanswered. Both are critical for future
policy, but each presents a challenge for
evaluation. First, itis notyet knownhow the
increase in case finding has affected, and
willaffect, thetransmission ofinfection, case
load, and mortality. If China has exceeded
theWHOtargetsof70%casedetectionand
85% treatment success, then we would
expect to see substantial reductions in
transmission and in the number of cases
and deaths. In this context, the findings of
the 2010 national TB prevalence survey,
now under way, will be crucial. The
reduction in prevalence obtained over the
past decade can be set against the invest-
ment in TB control over that period.
Second, while higher levels of funding
for TB control were clearly associated with
improved case notification, these new
resources were provided at about the same
time as China made other improvements
to health services. Starting in 2003, the
government progressively introduced three
newhealth financing mechanisms:the rural
cooperative medical scheme (insurance
coverage was especially low in rural areas),
the basic medical insurance system for
uninsured urban residents (children, elderly
people without pensions and the long-term
unemployed, but not migrants), and the
medical assistance programme (for those
who receive the minimum living allowance)
[9–11]. Those schemes have greatly ex-
tended the coverage of health care, al-
though data on insurance coverage and on
the utilization of township health facilities
suggest that the main effects did not occur
until after 2005 [9], by which time TB case
notification rates had stabilized.
On the basis of our results up to 2008,
we cannot yet anticipate the impact of
China’s latest health care reform plan
announced in 2009 [12]. The new plan
aims, among other things, to raise health
insurance coverage still further, establish a
national essential drugs system with price
regulation and reimbursement, provide
Table 1. Number and characteristics of counties in areas supported mainly by the World Bank, the Global Fund, and the central
and local Governments.
Group
Total Number
of Counties Number of Counties in Income Groups (% counties)
Average County
Expenditure, LCE
CNY/Person
Average Level of
Illiteracy in
Counties, ILR%
Number of Minority
Counties, MIN (%
Counties)
Poor General Developed
WB 1,649 443 (27) 1,188 (72) 18 (1) 0.042 11 328 (20)
GF 1,331 580 (43.7) 747 (56) 4 (0.3) 0.049 19 326 (25)
CG 512 16 (3) 418 (81) 78 (16) 0.061 9 4 (0.8)
The classification of counties is described in Text S1.
CG, Chinese government; GF, Global Fund; ILR, illiteracy rate; LCE, per capita expenditure; MIN, minority county; WB, World Bank.
doi:10.1371/journal.pmed.1000371.t001
Figure 2. Changes in TB case notifica-
tions in different areas of China from
2001 to 2008. Trends in (A) TB case
notification rates in areas supported by the
World Bank (WB), the Global Fund (GF) and
the Chinese government (CG); (B) the ratio of
male/female cases; (C) the ratio of cases in
people aged $65 years to cases in people
aged 15–64 years.
doi:10.1371/journal.pmed.1000371.g002
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overstretched city hospitals, improve
screening and prevention, and decommer-
cialize public hospitals. New infrastructure
will include thousands of township and
county hospitals, compliant with national
standards [9]. As China becomes more
reliant on domestic rather than foreign
investment, there is a premium on evalu-
ating the links between financing for
health in general and for TB control in
particular. Studies of this kind are rare,
Table 2. Expenditures (2001–2005) and budgets (2006–2008) for TB control from different areas and funding sources.
Area of Country
Identified by Main
Source of Funding Sources of Funding Indicator 2001 2002 2003 2004 2005 2006 2007 2008 Total
WB WB, UK Department for
International Development,
Japan International
Cooperation Agency, Damien
Foundation Belgium, central
and local government funds
matched to donors.
Expenditure or budget
(CNY millions)
53.1 109.9 165.5 521.9 529.5 514.7 548.2 583.7 3,026.5
Cost per person (CNY) 0.078 0.157 0.234 0.736 0.742 0.738 0.782 0.833 0.538
Case notifications
per 100,000 population
16.3 15.4 21.8 31.4 39.5 37.9 36.9 36.81 29.5
Cost per TB case notified
(CNY)
474 1,018 1,076 2,321 1,929 1,929 2,118 2,222 1,820
Cost per TB case
successfully treated (CNY)
496 1,065 1,124 2,457 2,053 2,052 2,262 2,380 1,930
Incremental cost per TB
case notified (CNY)
— — 1,215 3,525 2,521 2,549 2,907 3,063 2,778
a
(2,696)
GF GF, central and local
government funds
matched to donors.
Expenditure or budget
(CNY millions)
18.7 22.9 116.1 162.9 177.7 181.9 202.9 175.2 1,058.3
Cost per person (CNY) 0.077 0.095 0.475 0.663 0.721 0.766 0.855 0.722 0.546
Case notifications
per 100,000 population
15.9 13.3 19.5 31.85 43.1 42.4 42.7 42.1 31.3
Cost per TB case
notified (CNY)
482 711 2,350 2,057 1,732 1,819 2,046 1,713 1,763
Cost per TB case
successfully treated (CNY)
505 740 2,455 2,170 1,851 1,943 2,176 1,811 1,857
Incremental cost per TB
case notified (CNY)
— — 5,452 2,986 2,202 2,348 2,692 2,175 2,594
a
(2,890)
CG Central and local
government funding
Expenditure or budget
(CNY millions)
61.2 89.4 101.4 174.8 197.6 165.3 202.9 120.2 1,112.8
Cost per person (CNY) 0.187 0.271 0.304 0.519 0.580 0.464 0.559 0.330 0.404
Case notifications
per 100,000 population
15.7 16.6 19.3 24.9 27.5 26.6 27.1 26.8 23.2
Cost per TB case
notified (CNY)
1,187 1,637 1,588 2,090 2,046 1,819 2,191 1,233 1,763
Cost per TB case
successfully treated (CNY)
1,242 1,723 1,669 2,225 2,186 1,933 2,322 1,303 1,867
Incremental cost per TB
case (CNY)
— — 1,299 2,930 2,578 2,093 2,996 2,556 2,556
a
(2,560)
National total Expenditure or budget
(CNY millions)
133.0 222.3 382.9 860.6 904.9 861.9 954.0 879.1 5,197.6
Cost per person (CNY) 0.106 0.174 0.298 0.665 0.696 0.667 0.734 0.672 0.504
Case notifications
per 100,000 population
16.0 15.3 20.6 29.8 36.9 35.6 35.3 35.0 28.2
Cost per TB case
notified (CNY)
655 1,140 1,434 2,217 1,914 1,883 2,117 1,901 1,794
Cost per TB case
successfully treated (CNY)
686 1,194 1,500 2,348 2,037 2,005 2,256 2,024 1,901
Incremental cost per TB
case notified (CNY)
— — 2,230 33,04 2,449 2,434 2,864 2,455 2,639
a
(2,724)
aThese figures in the final column are averages over the period 2003–2008 (or 2003–2005 in brackets). Incremental costs are calculated in comparison with 2002.
CG, Chinese government; GF, Global Fund; WB, World Bank.
doi:10.1371/journal.pmed.1000371.t002
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policy for the control of diseases like
tuberculosis.
Supporting Information
AlternativeLanguageSummaryS1 Chi-
nese translation of the summary by ZJ and
SC.
Found at: doi:10.1371/journal.pmed.
1000371.s001 (0.03 MB DOC)
Text S1 Additional methods, models,
and results.
Found at: doi:10.1371/journal.pmed.
1000371.s002 (0.56 MB DOC)
Author Contributions
ICMJE criteria for authorship read and met: ZJ
SC ZL XD FH XJ PK YL WC WW CD. Agree
with the manuscript’s results and conclusions:
ZJ SC ZL XD FH XJ PK YL WC WW CD.
Designed the experiments/the study: ZJ SC YL
WW CD. Analyzed the data: ZJ SC ZL XD FH
XJ PK YL WC WW CD. Collected data/did
experiments for the study: ZJ SC XD FH XJ
PK WC. Enrolled patients: SC. Wrote the first
draft of the paper: ZJ ZL YL WW CD.
Contributed to the writing of the paper: ZJ
SC ZL XD FH XJ PK YL WC WW CD.
References
1. World Health Organization (2009) Global Tu-
berculosis Control 2009: Epidemiology, strategy,
finances. Geneva: World Health Organization.
2. World Health Organization and Stop TB Part-
nership (2007) The Action Plan for Global MDR-
TB and XDR-TB Control, 2007-2008. World
Health Organization.
3. Ministry of Health P. R. China (2009) Report on
status of national notifiable diseases in 2009. Mini-
stry of Health P. R. China. Available: http://www.
moh.gov.cn. Accessed 10 January 10 2010.
4. Raviglione MC, Uplekar MW (2006) WHO’s
new Stop TB Strategy. Lancet 18: 952–955.
5. Dye C, Zhao FZ, Scheele S, Williams B (2000)
Evaluating the impact of tuberculosis control:
number of deaths prevented by short-course
chemotherapy in China. Int J Epidemiol 29:
558–564.
6. China Tuberculosis Control Collaboration (2004)
The effect of tuberculosis control in China.
Lancet 364: 417–422.
7. Wang L, Liu J, Chin DP (2007) Progress in
tuberculosis control and the evolving public-
health system in China. Lancet 369: 691–696.
8. Floyd K, Arora VK, Murthy KJ, Lonnroth K,
Singla N, et al. (2006) Cost and cost-effectiveness
of PPM-DOTS for tuberculosis control: evidence
from India. Bull World Health Organ 84:
437–445.
9. Herd R, Hu YW, Koen V (2010) Improving
China’s health care system. OECD Economics
Department Working Papers. 751 p.
10. Dong KY (2009) Medical insurance system
evolution in China. China Econ Rev 20:
591–597.
11. Chen Z (2007) New rural cooperative medical
service will cover around whole country by 2008.
Xinhua 2007; 09–05.
12. Chen Z (2009) Launch of the health-care reform
plan in China. Lancet 373: 1322–1324.
PLoS Medicine | www.plosmedicine.org 6 November 2010 | Volume 7 | Issue 11 | e1000371